We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development
Read MoreHide Full Article
Key Takeaways
HCA agreed to acquire CHCP, a Texas-based allied healthcare training provider serving 8,000 students.
CHCP offers 20 accredited healthcare programs and has trained more than 52,000 students.
HCA aims to strengthen workforce development across 189 hospitals and 2,600 care sites.
HCA Healthcare, Inc. (HCA - Free Report) has agreed to acquire The College of Health Care Professions (“CHCP”), a Texas-based allied healthcare training provider. CHCP serves more than 8,000 students annually through 10 campuses across Texas and online programs. Financial terms of the transaction were not disclosed. Eric Bing will continue to lead CHCP as chancellor and CEO following the completion of the acquisition.
HCA Healthcare and CHCP have worked together for years through clinical training, advisory boards and career placement programs. In 2023, HCA Healthcare partnered with CHCP on a 12-week Medical Assistant training program for its urgent care centers across Texas. Since launch, more than 100 participants have graduated from the program and advanced their careers within HCA Healthcare. The deal reflects the companies’ shared focus on student success, academic quality and workforce readiness.
Founded in 1988, CHCP has trained more than 52,000 students and offers more than 20 accredited allied healthcare programs, including Medical Assisting, Sonography, Surgical Technology, Radiologic Technology and Medical Coding and Billing. The acquisition expands HCA Healthcare’s workforce development and healthcare education initiatives and could help strengthen its pipeline of trained healthcare professionals across its network of 189 hospitals and approximately 2,600 ambulatory care sites.
HCA Healthcare continues to broaden its education-focused investments through nursing schools, campus expansion initiatives and workforce development programs. In 2020, the company acquired a majority interest in Galen College of Nursing and has since expanded the institution to 25 campuses nationwide. HCA Healthcare also supports additional nursing institutions and healthcare career training programs. The CHCP acquisition further aligns with the company’s efforts to strengthen its long-term healthcare workforce pipeline and support future growth.
HCA’s Stock Price Performance
Shares of HCA Healthcare have gained 3.6% over the past 12 months against the industry’s 1.2% decline.
The Zacks Consensus Estimate for Surgery Partners’ 2026 earnings is pegged at 23 cents per share, which has witnessed two upward revisions in the past 30 days, with no movement in the opposite direction. The consensus estimate for SGRY’s 2026 revenues is pinned at $3.42 billion, implying 3.4% year-over-year growth.
The Zacks Consensus Estimate for Tenet Healthcare’s 2026 earnings is pegged at $17.67 per share, which has witnessed eight upward revisions in the past 30 days, with no movement in the opposite direction. THC beat earnings estimates in each of the trailing four quarters, with the average surprise being 20.6%. The consensus estimate for 2026 revenues is pinned at $22.02 billion, implying 3.4% year-over-year growth.
The Zacks Consensus Estimate for Concentra Group’s 2026 earnings is pegged at $1.53 per share, which has witnessed four upward revisions in the past 30 days, with no movement in the opposite direction. CON beat earnings estimates in each of the trailing four quarters, with the average surprise being 10.4%. The consensus estimate for 2026 revenues is pinned at $2.33 billion, implying 7.5% year-over-year growth.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development
Key Takeaways
HCA Healthcare, Inc. (HCA - Free Report) has agreed to acquire The College of Health Care Professions (“CHCP”), a Texas-based allied healthcare training provider. CHCP serves more than 8,000 students annually through 10 campuses across Texas and online programs. Financial terms of the transaction were not disclosed. Eric Bing will continue to lead CHCP as chancellor and CEO following the completion of the acquisition.
HCA Healthcare and CHCP have worked together for years through clinical training, advisory boards and career placement programs. In 2023, HCA Healthcare partnered with CHCP on a 12-week Medical Assistant training program for its urgent care centers across Texas. Since launch, more than 100 participants have graduated from the program and advanced their careers within HCA Healthcare. The deal reflects the companies’ shared focus on student success, academic quality and workforce readiness.
Founded in 1988, CHCP has trained more than 52,000 students and offers more than 20 accredited allied healthcare programs, including Medical Assisting, Sonography, Surgical Technology, Radiologic Technology and Medical Coding and Billing. The acquisition expands HCA Healthcare’s workforce development and healthcare education initiatives and could help strengthen its pipeline of trained healthcare professionals across its network of 189 hospitals and approximately 2,600 ambulatory care sites.
HCA Healthcare continues to broaden its education-focused investments through nursing schools, campus expansion initiatives and workforce development programs. In 2020, the company acquired a majority interest in Galen College of Nursing and has since expanded the institution to 25 campuses nationwide. HCA Healthcare also supports additional nursing institutions and healthcare career training programs. The CHCP acquisition further aligns with the company’s efforts to strengthen its long-term healthcare workforce pipeline and support future growth.
HCA’s Stock Price Performance
Shares of HCA Healthcare have gained 3.6% over the past 12 months against the industry’s 1.2% decline.
Image Source: Zacks Investment Research
HCA’s Zacks Rank & Key Picks
HCA currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Medical space are Surgery Partners, Inc. (SGRY - Free Report) , sporting a Zacks Rank #1 (Strong Buy) at present, and Tenet Healthcare Corporation (THC - Free Report) and Concentra Group Holdings Parent, Inc. (CON - Free Report) , both carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Surgery Partners’ 2026 earnings is pegged at 23 cents per share, which has witnessed two upward revisions in the past 30 days, with no movement in the opposite direction. The consensus estimate for SGRY’s 2026 revenues is pinned at $3.42 billion, implying 3.4% year-over-year growth.
The Zacks Consensus Estimate for Tenet Healthcare’s 2026 earnings is pegged at $17.67 per share, which has witnessed eight upward revisions in the past 30 days, with no movement in the opposite direction. THC beat earnings estimates in each of the trailing four quarters, with the average surprise being 20.6%. The consensus estimate for 2026 revenues is pinned at $22.02 billion, implying 3.4% year-over-year growth.
The Zacks Consensus Estimate for Concentra Group’s 2026 earnings is pegged at $1.53 per share, which has witnessed four upward revisions in the past 30 days, with no movement in the opposite direction. CON beat earnings estimates in each of the trailing four quarters, with the average surprise being 10.4%. The consensus estimate for 2026 revenues is pinned at $2.33 billion, implying 7.5% year-over-year growth.